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COMMISSION STAFF WORKING DOCUMENT 
Implementation of the Health Programme in 2010 
1. INTRODUCTION 
Article 13(1) of Decision No 1350/2007/EC of the European Parliament and of the Council of 
23 October 2007 establishing a second programme of Community action in the field of health 
(2008-13)1 requires that the Commission report yearly to the Health Programme Committee 
on all actions and projects funded through the Programme and keep the European Parliament 
and the Council informed. The purpose of this working document is to fulfil this requirement. 
This working document provides detailed information on the budget for 2010 and its 
execution. Moreover, examples of key results of actions funded in 2010 are provided in an 
appendix to this report. 
2. BUDGET 
The budget for the second Health Programme for the period 2008-2013 is EUR 321.5 million. 
The estimated budget set out in the work plan for 2010 was EUR 47.1 million. This was 
broken down as follows: 
• Operational expenditure: EUR 45.7 million corresponding to budget line 17 03 06 — 
Community action in the field of health. With EFTA/EEA and Croatia credits as well 
as recovery credits from previous budgetary years, the total operational budget 
amounted to EUR 47.4 million. 
• Administrative expenditure: EUR 1.4 million corresponding to budget line 
17 01 04 02 — Expenditure on administrative management. 
The Executive Agency for Health and Consumers (EAHC) has provided the Commission with 
technical, scientific and administrative assistance in implementing the Health Programme 
since 20052. The EAHC organises annual calls for proposals, coordinates the evaluation of 
submissions, and negotiates, signs and manages related contracts. The EAHC is also 
responsible for most procurement procedures. In 2010, the Agency managed 
EUR 40.8 million, and the Commission managed the remaining EUR 6.6 million. 
3. PRIORITIES FOR 2010 AND FINANCING MECHANISMS 
The priorities for 2010 were set out in Commission Decision 2009/964/EU of 18 December 
2009 adopting the 2010 work plan and related criteria3. Commission Decision 2010/C 358/04 
                                                 
1 OJ L 301, 20.11.2007, p. 3. 
2 Decision 2004/858/EC of 15 December 2004 (OJ L 369, 16.12.2005, p. 73) amended by Decision 
2008/544/EC of 20 June 2008 (OJ L 173, 3.7.2008, p. 27). 
3 OJ L 340, 22.12.2009, p. 1. 
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of 22 December 20104 amended that Decision. The amendment was introduced as a result of 
changes in the implementation of the work plan. This led to changes in the distribution of the 
budget among the various financing mechanisms. The changes exceeded the 20 % margin set 
out in Article 1(2) of Commission Decision 2009/964/EU, making it necessary to amend 
Decision 2009/964/EU. 
The following financing mechanisms were used to implement the work plan for 2010: 
• Project grants: these are awarded to projects involving several partners, usually 
public health bodies and non-governmental organisations (NGOs). The maximum 
EU contribution is 60 % of eligible costs. 
• Conference grants: these go towards conferences on public health issues, organised 
by public bodies or non-profit organisations and the Council Presidencies. The 
maximum EU contribution is 50 % of eligible costs. 
• Operating grants: these are awarded to non-profit organisations or specialised 
networks in the field of health. Such bodies must be non-governmental, non-profit 
making, independent of industry or other conflicting interests and have as their 
primary objectives one or more goals of the Programme. The maximum EU 
contribution is 60 % of their annual operating costs. 
• Grants for joint actions: these are awarded to Member States’ authorities or bodies 
designated by them. The maximum EU contribution is 50 %. 
• Direct grant agreements with international organisations — awarded to international 
organisations active in the area of public health: the Organisation for Economic 
Cooperation and Development (OECD), the World Health Organization (WHO), the 
Council of Europe, the International Agency for Research on Cancer (IARC) and the 
European Observatory on Health Policies and Health Systems. The maximum EU 
contribution is 60 %. 
• Procurement (service contracts): these are used to purchase services, such as 
evaluations, studies, data procurement and IT applications. The Health Programme 
covers the full cost of these. 
Competitive selection and award procedures are used to select actions for funding, with the 
exception of direct grant agreements and conferences organised by Council Presidencies. 
Administrative credits cover expenditure such as studies, meetings of experts, information and 
publication costs, and technical and administrative assistance for IT systems. 
                                                 
4 OJ L C 358, 31.12.2010, p. 23. 
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4. IMPLEMENTATION OF THE OPERATIONAL BUDGET BY FINANCING MECHANISM 
Number of 
grants / 
contracts 
signed 
Type of financing mechanism Implementation 
€ 
Share of 
mechanism in 
total executed 
budget  
   Call for proposals: 35.313.433.00 75.27 % 
20 Project grants 16.225.324.00 34.58 % 
11 Conference grants 899.339.00 1.92 % 
9 Operating grants 2.322.774.00 4.95 % 
10 Grants for joint actions 15.865.996.00 33.82 % 
10 Direct grant agreements 2.600.000.00 5.54 % 
 Procurement (service contracts) 8.231.411.00 17.55 % 
 Scientific Committees 270.000.00 0.58 % 
 Other: JRC 500.000.00 1.07 % 
  Executed budget in 2010 46.914.844.00  
  Total available budget 47.365.553.00  
 Credits not used (pre-accession 
credits not yet used, differences 
between amounts in the award 
decision and amounts actually 
contracted) 
450.709.00  
 Level of budget execution 99.05 %  
4.1. Call for proposals 
The call for proposals consists of the following parts: 
• a call for proposals for projects, 
• a call for proposals for conferences, 
• a call for proposals for operating grants, 
• a call for proposals for joint actions. 
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The call was launched on 22 December 2009 and closed on 19 May 2010. Announcements 
were published in the Official Journal5, the Public Health Europa website6 and the EAHC 
website7. 
On 13-14 January 2010 the EAHC organised a workshop in Luxembourg on how to prepare 
project proposals. Participation was open to those planning to submit proposals. In addition, 
11 Member States organised national information days. Guides for applicants were made 
available on the EAHC website. The EAHC helpdesk also provided assistance and practical 
help. 
In all, 177 applications were submitted for requested funding totalling EUR 117.858 million. 
The proposals were evaluated in accordance with the rules and criteria set out in Commission 
Decision 2009/964/EU and the calls for proposals. The proposals were reviewed by 39 
external experts drawn from a list that was established following a call for expressions of 
interest ‘Experts for the second programme of Community action in the field of health in 
various evaluation activities’8. 
The evaluation took place in two stages. 
In the first stage, three external evaluators reviewed each proposal, and the Commission 
departments assessed the policy relevance of each of the proposed projects. 
In the second stage, an evaluation committee checked that the evaluators had adhered to the 
relevant rules and criteria. It then drew up final lists of proposals recommended for funding 
together with reserve lists. The evaluation committee comprised representatives from the 
Directorate-General for Health and Consumers, the Directorate-General for Research and 
Innovation, Eurostat and the EAHC. 
At its meeting on 7 July 2010 the committee of the second programme of Community action 
in the field of health (2008-13) issued a favourable opinion on the activities proposed for 
funding. The Commission adopted the related awarding Decision on 27 October 20109. 
Following the amendment of the 2010 work plan on 22 December 2010, a number of 
additional projects and one joint action were funded from the reserve lists which had been 
drawn up. 
4.1.1. Project grants 
In all, 115 proposals were submitted in response to the call for proposals for projects and 17 
proposals were recommended for funding. Three proposals were placed on a reserve list. In 
the end, 20 projects were funded for a total of EUR 16 225 324. Their distribution among the 
programme objectives was as follows: 
                                                 
5 OJ C 313, 22.12.2009, p. 16. .  
6 http://ec.europa.eu/health/programme/application/index_en.htm. 
7 http://ec.europa.eu/eahc. 
8 OJ S 28, 9.02. 2008 and http://ec.europa.eu/phea/phea_ami/. 
9 http://ec.europa.eu/health/programme/docs/award_decision2010.pdf. 
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– Health security: EUR 3 534 667 (5 projects) 
– Health promotion, including the reduction of health inequalities: EUR 12 083 314 
(14 projects) 
– Health information: EUR 607 343 (1 project). 
A table in Annex 1 lists the projects funded. The EAHC database, which is publicly 
accessible on the Internet10, provides abstracts of these. 
4.1.2. Conference grants 
Apart from 2 Presidency conferences, 27 proposals were submitted in response to the call for 
proposals for conferences. Of these, 8 were recommended for funding and 2 were put on the 
reserve list. In the end, 11 conferences were funded for a total of EUR 899 339: two 
Presidency conferences, one under the Belgian Presidency and one under the Hungarian 
Presidency, and 9 conferences under the call for proposals. The distribution among the 
programme objectives was as follows: 
– Health promotion: EUR 456 369 (4 conferences) 
– Health information: EUR 442 970 (5 conferences). 
The issues addressed in the conferences which were funded included cancer, child health, 
HIV, injury prevention and patients’ rights. A table in Annex 2 lists the conferences funded. 
The EAHC database provides abstracts of these. 
The conference organised by the Belgian Presidency focused on chronic diseases, and the 
conference organised by the Hungarian Presidency focused on prevention. 
4.1.3. Operating grants 
A total of 25 proposals were submitted in response to the call for proposals for operating 
grants. Of these, 6 were renewal applications. In the end, 9 proposals ─ 5 new proposals and 4 
renewal proposals ─ were funded for a total of EUR 2 322 774. They all came under the 
objective ‘Health promotion’. 
New operating grants were awarded to: Assistance publique des hôpitaux de Paris (rare 
diseases networks: porphyria); Assistance publique des hôpitaux de Paris (rare diseases 
networks: Wilson’s disease); the Association of Schools of Public Health in the European 
Region; European Alcohol Policy Alliance and Stichting Health Action International. 
Renewals were awarded to: Alzheimer Europe; the European Organisation for Rare Diseases; 
European Public Health Alliance and Stichting Aids Fonds — Soa Aids Nederland. 
Annex 3 contains a table listing the operating grants which received funding. The EAHC 
database provides abstracts of these. 
                                                 
10 http://ec.europa.eu/eahc/projects/database.html. 
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4.1.4. Joint actions 
2010 was a record year for joint actions, with 10 being funded for a total of EUR 15 865 996. 
They were distributed among the programme objectives as follows: 
– Health security: EUR 3 600 573 (2 joint actions) 
– Health promotion: EUR 10 626 371 (6 joint actions) 
– Health information: EUR 1 639 052 (2 joint actions). 
These joint actions, with the participation of a large number of Member States and third 
countries taking part in the Programme, focused on: Alzheimer’s; eHealth; European Health 
and Life Expectancy Information System; cancer; health inequalities; surveillance of 
congenital anomalies; injury monitoring; organ donation and transplantation; rare diseases 
and orphan medicines; and the detection of highly infectious pathogens. 
All the joint actions selected for funding were signed between 30 December 2010 and 
1 August 2011. 
Annex 4 contains a table listing the joint actions which were funded. The EAHC database 
provides abstracts of these. 
4.2. Direct grant agreements with international organisations 
In all, 5 direct grant agreements were signed for a total of EUR 2 600 000 with the following 
international organisations: 
– Council of Europe ─ cooperation on substances of human origin; 
– European Observatory on Health Policies and Health Systems ─ Commission membership 
fee to the Observatory; 
– International Agency for Research on Cancer ─ data, information and knowledge on 
cancer; 
– Organisation for Economic Cooperation and Development ─ cooperation on key areas of 
the OECD Health Committee; 
– World Health Organization ─ joint data gathering on the alcohol situation and policies in 
the Member States. 
A table in Annex 5 lists the direct grant agreements which were funded. 
4.3. Procurement (service contracts) 
Altogether, 79 service contracts were signed for a total of EUR 8 231 411. They were 
distributed among programme objectives and IT applications in support of programme 
implementation as follows: 
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Programme objective 
Tenders / 
contracts 
SANCO 
Tenders / 
contracts EAHC Total 
Health Security 596.703 763.901 1.360.604
Health Promotion 1.521.438 1.312.175 2.833.613
Health Information  1.792.749 629.095 2.421.844
Information technologies 1.615.350 0 1.615.350
Total 5.526.240 2.705.171 8.231.411
 
These service contracts covered needs as specified in the work plan for 2010: evaluation and 
monitoring; studies; provision of advice, data and information on health; scientific and 
technical assistance; communication and awareness-raising activities and IT applications in 
support of policy design and implementation. 
A table in Annex 6 lists the service contracts which were funded. 
4.4. Scientific Committees 
The objective of Scientific Committees is to provide the Commission with high quality, 
independent advice on health risks. Funding from the Health Programme supports the 
functioning of Scientific Committees in accordance with Commission Decision 
2008/721/EC11. Special indemnities are paid to experts for taking part in meetings and their 
work on scientific opinions. 
A sum of EUR 270 000 was earmarked for this in 2010. 
4.5. Other 
Based on an administrative agreement with the Joint Research Centre (JRC), a sum of 
EUR 500 000 went towards work on the Health Emergency and Diseases Information System 
(Hedis) and the Medical Intelligence System (Medisys). 
5. IMPLEMENTATION OF THE OPERATIONAL BUDGET BY PROGRAMME OBJECTIVES 
5.1. Global budget consumption in 2010 
The graph below illustrates the consumption of the budget in 2010 according to the three 
programme objectives: Health Security, Health Promotion and Health Information. It also 
covers IT spending and shows the unused budget. 
In the following sections the graphs and tables give details of budget consumption according 
to the three programme objectives. 
                                                 
11 OJ L 241, 10.9.2008, p. 21. 
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5.2. Health security — EUR 9.365.844 – 20 % of the operational budget in 2010 
 
HEALTH SECURITY  
Prevention and control of communicable diseases 4.712.698.00
Emergency preparedness 2.276.904.00
Enhancing response capacity 1.226.491.00
Scientific advice 429.383.00
Safety of substances of human origin 720.368.00
TOTAL 9.365.844.00
Health Programme budget in 2010 47.365.553.00
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5.3. Health promotion EUR 29.722.441 – 63 % of the operational budget in 2010 
 
HEALTH PROMOTION 
Public health capacity building 120.266.00
Reduction of health inequalities 2.012.743.00
Children and young people 98.512.00
Health and work 587.575.00
Nutrition and physical activity 1.993.418.00
Mental health 3.420.534.00
Major and chronic diseases 6.017.458.00
Rare diseases 9.005.328.00
Sexual health and HIV-AIDS 1.239.960.00
Tobacco 489.432.00
Alcohol 1.124.441.00
Illicit drugs 900.000.00
Injury prevention 1.712.774.00
TOTAL 29.722.441.00
Health Programme budget in 2010 47.365.553.00
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5.4. Health information — EUR 6.211.209 – 13 % of the operational budget in 2010 
 
HEALTH INFORMATION 
Exchange knowledge and best practice 568.840.00
Collect, analyse and disseminate health 
information 2.810.425.00
European Health Information System 2.494.357.00
Dissemination and application of health 
information 332.787.00
Analysis and reporting 4.800.00
TOTAL 6.211.209.00
Health Programme budget in 2010 47.365.553.00
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ANNEX 1 –Project grants (signed and committed) 
HEALTH SECURITY 
3.2.1.1. Prevention and control of communicable diseases 
Acronym Title Amount 
HProImmune Promotion of immunisation for Health Professionals in Europe 603 900 
EU-HEP-SCREEN Screening for Hepatitis B and C among migrants in the European Union+ 792 816 
3.2.1.2. Emergency preparedness 
FLURESP Cost-effectiveness assessment of European influenza human pandemic alert and response 
strategies 
699 220 
PHASE Public Health Adaptation Strategies to Extreme weather events 744 038 
3.2.1.3. Enhancing response capacity 
TUBIDU Empowering Civil society & Public Health system to fight tuberculosis Epidemic Among 
Vulnerable groups 
694 693 
Total 3 534 667 
HEALTH PROMOTION 
3.3.2. Promote healthier ways of life and reduce major diseases and injuries by tackling health determinants 
3.3.2.2. Health and work 
PHWork Promoting Healthy Work for Employees with Chronic Illness — Public Health & Work 587 575 
3.3.2.3. Nutrition and physical activity 
MOVE European Physical Activity Promotion Forum 676 020 
SALUS A European network to follow up the reformulation of food. Identification & Exchange of 
good practices for SMEs & Consumers 
834 688 
3.3.2.5. Mental health 
PRO YOUTH Promotion of young people’s mental health through technology-enhanced personalisation 
of care 
930 378 
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EUROGENAS European regions enforcing actions against suicide 750 000 
PREDI-NU Preventing Depression and Improving Awareness through Networking in the EU 1 099 032 
3.3.2.7 Prevention of major and chronic diseases and rare diseases 
Major and chronic diseases 
EuroHeart II European Heart Health Strategy II 1 149 364 
Rare diseases 
E-IMD European registry and network for Intoxication type Metabolic Diseases 779 746 
EURO-WABB An EU rare diseases registry for Wolfram syndrome, Alstrom syndrome & Bardet Biedl 
syndrome 
900 000 
EPIRARE Building Consensus and Synergies for the EU Registration of Rare Disease patients 661 402 
EUReMS European Register for Multiple Sclerosis — A tool to assess, compare and enhance the 
status of people with MS throughout the EU 
987 198 
3.3.2.4. Sexual health and HIV-AIDS 
SIALON II Capacity building in combining targeted prevention with meaningful HIV surveillance 
among MSM 
989 960 
3.3.2.6. Addiction prevention  
Illicit drugs 
NEW Implementation Nightlife Empowerment and Well-being Implementation project 900 000 
3.3.2.9. Injury prevention 
TACTICS Tools to address childhood Trauma, Injury and Children’s Safety 837 951 
Total 12 083 314 
HEALTH INFORMATION 
3.4.2. Collect, analyse and disseminate health information 
EURO-PERISTAT Promoting better health for mothers and babies through routine European monitoring of 
perinatal health and health care 
607 343 
Total 607 343 
TOTAL PROJECTS 16 225 324 
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ANNEX 2 — Conference grants (signed and committed) 
HEALTH PROMOTION 
3.3.1. Foster healthier ways of life and reduce health inequalities 
3.3.1.3. Reduction of health inequalities  
Acronym Title Amount 
Bridges for CHILD  CHILD-Combating Health Inequalities in Life-threatening diseases  96 500 
3.3.2. Promote healthier ways of life and reduce major diseases and injuries by tackling health determinants 
3.3.2.1. Children and young people 
YEP — Youth Cancer 
Conference 
Cancer Education and Awareness for all Young People 49 869 
3.3.2.6. Addiction prevention — Tobacco 
ECToH2011 European Conference on Tobacco or Health 2011 50 000 
3.3.2.9. Injury prevention 
InjuryConf-2011 Tackling the challenges of implementing good practices in safety promotion — 
EUROSAFE 
85 000 
Presidency conferences 
Chronic diseases — BE Innovative approaches for chronic illness in Public health and healthcare systems 100 000 
PREVACT — HU Action for Prevention 75 000 
Total 456 369 
HEALTH INFORMATION 
3.4.1. Exchange knowledge and best practice 
AIDS 2011 HIV in Europe — unity and diversity 100 000 
CCC Continuing Cancer Care 20 845 
Copenhagen 2011 Fourth Joint European Public Health Conference 150 000 
EU Patients and Rights 
Day 
5th European Patients and Rights Day: Putting Citizens at the Centre of EU Health Policy 75 125 
FEMP2011 Men, Men, Sex and HIV 2011 — The Future of European MSM Prevention 100 000 
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Total 442 970 
TOTAL CONFERENCES 899 339 
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ANNEX 3 –Operating grants (signed and committed) 
HEALTH PROMOTION 
3.3.1. Foster healthier ways of life and reduce health inequalities 
3.3.1.2. Public health capacity building 
Acronym Title Amount 
EPHA European Public Health Alliance — renewal OG 2009 550 000 
HAI Stichting Health Action International 218 000 
ASPHER  The Association of Schools of Public Health in the European Region 160 000 
3.3.2.7. Prevention of major and chronic diseases and rare diseases 
Major and chronic diseases 
AE Alzheimer Europe — renewal OG 2009 200 000 
Rare diseases 
AP-HP WILSON Rare diseases network — Wilson’s disease; Assistance publique des hôpitaux de Paris 168 160 
EURORDIS European Organisation for Rare Diseases — renewal OG 2009 580 000 
AP-HP Porphyria Rare diseases network — Porphyria; Assistance publique des hôpitaux de Paris 99 250 
3.3.2.4. Sexual health and HIV-AIDS 
SANL Stichting Aids Fonds ~ Soa Aids Nederland — renewal OG 2009 250 000 
3.3.2.6. Addiction prevention  
Alcohol 
EUROCARE European Alcohol Policy Alliance 99 000 
TOTAL OPERATING GRANTS 2 322 774 
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ANNEX 4 –Joint actions (signed and committed) 
HEALTH SECURITY 
3.2. Improve citizen’s health security  
3.2.2. Improve citizen’s safety 
Acronym Title Amount 
MODE Mutual Organ Donation and Transplantation Exchanges 293 060 
3.2.1.1. Prevention and control of communicable diseases 
QUANDHIP Quality Assurance Exercises and Networking on the Detection of Highly Infectious Pathogens 3 315 982 
Total 3 600 573 
HEALTH PROMOTION 
3.3.1. Foster healthier ways of life and reduce health inequalities 
3.3.1.3. Reduction of health inequalities 
EQUITY ACTION Joint Action on Health Inequalities 1 700 000 
3.3.2.7 Prevention of major and chronic diseases and rare diseases 
Major and chronic diseases  
EPAAC European Partnership for Action Against Cancer 3 212 278 
ALCOVE ALzheimer COoperative Valuation in Europe 638 163 
Rare diseases 
EUROCAT European Surveillance of Congenital Anomalies 1 106 302 
ORPHANET European portal of rare diseases and orphan drugs 3 295 857 
3.3.2.9. Injury prevention 
JAMIE Joint Action on Monitoring Injuries in Europe 790 773 
Total 10 626 371 
HEALTH INFORMATION 
3.4.2. Collect, analyse and disseminate health information 
EHLEIS European Health and Life Expectancy Information System 643 259 
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3.4.2.1. European Health Information System 
JA- EHGov  Joint Action eHealth Governance Initiative 1 001 970 
Total 1 639 052 
TOTAL JOINT ACTIONS 15 865 996 
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ANNEX 5 –Direct grant agreements with international organisations (signed and committed) 
HEALTH SECURITY 
3.2.2.3. Safety of substances of human origin 
Organisation Title Amount 
Council of Europe Cooperation with the CoE on specific matters related to human substances 100 000 
Total 100 000 
HEALTH PROMOTION 
3.3.2. Promote healthier ways of life and reduce major diseases and injuries by tackling health determinants 
3.3.2.7. Prevention of major and chronic diseases and rare diseases 
Major and chronic diseases  
IARC Data, information and knowledge on cancer  800 000 
3.3.2.6. Addiction prevention 
Alcohol 
WHO Cooperation between the EC and the WHO Regional Office for Europe on further 
development of joint data gathering and common knowledge base relating to the alcohol 
situation and alcohol policies in Member States 
600 000 
Total 1 400 000 
HEALTH INFORMATION 
3.4.2. Collect, analyse and disseminate health information 
OECD Cooperation on key areas of work of the Health Committee of the OECD 600 000 
Observatory European Observatory on Health Policies and Health Systems — Membership Fee 500 000 
Total 1 100 000 
TOTAL DIRECT GRANTS 2 600 000 
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ANNEX 6 — List of service contracts — procurement (signed and committed) 
HEALTH SECURITY 
3.2.1.2. Emergency preparedness 
Title Amount 
Organisation of training of staff and conducting exercises at European level as a fundamental element of 
preparedness — HPA 
333 646 
3.2.1.3. Enhancing response capacity 
Developing evidence-based, scientifically validated public health counter-measures 243 610 
Establishing risk assessment networks of toxic industrial chemicals and radioactive threats and risks 249 534 
Specific contract lab exercises 38 654 
3.2.2.2. Scientific advice 
Literature search — publications health and environment  12 372 
Editorial guidelines layout opinions  8 847 
Editorial work on rules of procedure for scientific committees 1 577 
Investigate the scientific basis for the term ‘nanomaterials’ 7 171 
Literature search for sources on mixture toxicity 8 306 
Editorial support for the SCENIHR opinion on nanomaterials 2 763 
Editorial support — food-imitating products 2 763 
Editorial support for the SCENIHR opinion on weight of evidence 2 154 
Editorial work on SCENIHR opinion — artificial light 3 381 
Editorial support for opinion on TTC  2 000 
Editorial support for opinion on fluoridation 2 309 
Editorial support for opinion on risk assessment 1 536 
Web-based text – opinion of non-food committee 17 645 
Literature search — nitrosamine 11 439 
Literature search — nitrosamine 14 023 
Data on nano effects 12 310 
Literature search — nanomaterials in medical devices 11 137 
Complementary commitment for Media Consulta 2009 13 500 
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Literature search — health effects of swimming pools 4 835 
Literature search — health effects of aircraft cabins 4 835 
CD Rom and newsletter 8 177 
Synthetic biology workshop 6 303 
3.2.2.3. Safety of substances of human origin 
Training health professionals 270 757 
Banner organ donation 18 756 
Workshop 2011 — Ligaris on organ donation 23 000 
Workshop 2011 — Ligaris on organ donation  23 264 
Total 1 360 604 
HEALTH PROMOTION 
3.3.1. Foster healthier ways of life and reduce health inequalities 
3.3.1.2.Public health capacity building 
Expertise, advice and production of scientific data 58 796 
Use of existing framework contract with the EPHA for the Health Forum 134 106 
3.3.1.3. Reduction of health inequalities 
Preparation of a report on health inequalities in the EU 249 948 
3.3.2. Promote healthier ways of life and reduce major diseases and injuries by tackling health determinants 
3.3.2.1. Children and young people 
Conference on Youth Health Initiative 2010 — Food for Mind — Mind for Health — 22-24/10/2010 — Torino 48 643 
3.3.2.3. Nutrition and physical activity 
Sharing of know-how on Community based initiatives to reduce overweight and obesity 74 294 
Belgian Presidency Conference on Nutrition 8-9.12.2010 — Ligaris 99 815 
Use of existing framework contract with EVENT TECH for nutrition and physical activity 233 601 
3.3.2.5. Mental health 
Study, in three parts, assessing mental health systems, situations and outcomes in Member States 299 507 
Berlin Conference on mental health — 3-4/3/2011 99 300 
Scientific contract for conference in Berlin on mental health 72 594 
Conference in Lisbon, expert advice, production of scientific documentation 69 729 
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Organisation of Lisbon conference 99 994 
3.3.2.7 Prevention of major and chronic diseases and rare diseases 
Rare diseases 
Orphan medicines 181 295 
Orphan medicines — Creation of a mechanism for the exchange of knowledge between Member States and 
European authorities on the scientific assessment of the clinical added value for orphan medicines 
247 118 
3.3.2.6. Addiction prevention  
Tobacco 
Support for the implementation of EU policy on tobacco control, in particular in raising awareness of health risks 5 000 
2 studies on cigarette packaging 369 000 
Availability, accessibility, usage and regulatory environment for new tobacco and nicotine products 65 432 
Alcohol 
EU-wide overview of the market and regulation regarding types of alcoholic beverages with particular appeal to 
minors 
99 979 
Studies on the affordability of alcoholic beverages 94 602 
European Alcohol & Health forum — scientific work first semester 89 392 
European Alcohol & Health forum 115 568 
Assessing quality of 2010 monitoring activities by members of EAHF 25 900 
Total 2 833 613 
HEALTH INFORMATION 
3.4.1. Exchange of knowledge and best practice 
Participation in the 20th IUHPE world conference on health, Geneva 125 870 
3.4.2. Collect, analyse and disseminate health information 
Evaluation of the impact of Structural Funds investments on health gains 467 570 
5 Eurobarometers (electromagnetic fields, rare diseases, mental health, patients’ rights, tobacco) 1 098 354 
3.4.2.1. European Health Information System 
Mutual Recognition of Medical Prescriptions: State of Play 161 525 
Study in support of the identification and development of a non-exhaustive list of elements to be included in 
prescriptions 
110 938 
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Level 1 commitment for WIKI project 120 000 
3.4.2.2. Dissemination and application of health information 
Provisional journalist prize 25 000 
Publication Journal: Promotion of the portal on the Agenda of Journalists of Italy  1 600 
Publication Journal: Promotion of the portal on the Agenda of Journalists of BE NL 1 250 
Publication Journal: Promotion of the portal on the Agenda of Journalists of BE FR 1 250 
Video and DVD ‘Health in all policies’  57 970 
Schema directeur comm  36 318 
Conference on global health Banner 17 674 
Third European Public Health Conference 26 764 
European Health forum Gastein 6 – 9 Oct 2010 164 961 
3.4.3. Analysis and reporting 
Impact of youth health on EU economy 4 800 
Total  2 421 844 
IT applications in support of programme implementation 
Service providers 1 615 350 
Total 1 615 350 
TOTAL PROCUREMENT (SERVICE CONTRACTS) 8 231 411 
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Appendix Annual Report 2010 
Key results of actions funded under the Health Programme 
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The following projects produced key results in 2010 and represent all strands. 
1. HEALTH SECURITY 
1.1. European Union Standards and Training for the Inspection of Tissue 
Establishments — project 
http://www.sohovs.org/soho/mod/resource/view.php?id=43 
Programme Objective: Health Security. Area: Substances of human origin. 
The project was funded under the first Public Health Programme 2003-2008, under the 2005 
work plan, with total cofunding from the EU of € 1.226.827. It started in December 2006 and 
ended in December 2009. 
Background information 
The European Union Standards and Training for the Inspection of Tissue Establishments 
project (EUSTITE) is an example of EU-wide cooperation in the area of public health directly 
related to EU legislation, and specifically Directive 2004/23/EC on substances of human 
origin and its associated implementing directives. To ensure the quality and safety of blood, 
tissues and cells, all Member States are obliged to comply with the standards laid down in EU 
legislation. 
The objective of the project was to review the standards and methods applied by the national 
competent authorities in the inspection and authorisation of tissue procurement and tissue 
establishments within the EU, by bringing together a wide consortium of 11 organisations 
from 10 EU Member States and the World Health Organization, to analyse their advantages 
and disadvantages. 
Main achievements 
The project produced significant results, based on an initial analysis which showed that 
national inspection systems are at very different stages of development and highlighted the 
considerable disparities between Member States in the implementation of common legislation. 
While recognising these differences in approach and acknowledging their advantages and 
disadvantages in national practice, the project contributed to the need for guidelines and 
training on how to conduct inspections in order to ensure a common approach. This approach 
was strengthened as a result of the following deliverables and guides made available in 2010. 
• Guidelines for the inspection of tissue and cells procurement establishments. 
• Guidelines for national competent authorities. 
• EUSTITE inspector training programme for tissue and cells inspectors. 
• Implementation guides for the tissues and cells directives. 
• International tissue and cell distribution. 
• Common reporting system for serious adverse events and reactions. 
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1.2. Increasing Public Health Safety for the External Borders of an Enlarged 
European Union — project 
http://www.iom.int/jahia/webdav/shared/shared/mainsite/activities/health/PHBLM-Project-
Summary-Brief-011209.pdf 
Programme Objective: Health Security. Area: Cross-Border Health Threats. 
The project was funded under the first Public Health Programme 2003-2008, under the 2006 
work plan, with total funding from the EU of € 471.076. The project started in June 2007 and 
was concluded in June 2010. 
Background information 
The EU faces increased and more complex migration flows. The inherent challenges have 
been amplified through the enlargement of the Schengen zone. Health systems and border 
services need to be prepared to address general public health concerns. They need also to 
respond to the health needs and rights of migrants, while at the same time safeguarding their 
own staff’s occupational health. 
The project ‘Increasing Public Health Safety for the External Borders of an Enlarged 
European Union’ (PHBLM) first assessed the magnitude and nature of current public health 
threats and hazards in border regions, and identified the needs for improvement and structural 
change. The safety and healthcare of border management staff and migrants themselves were 
at the heart of the recommendations of the project, which further developed a comprehensive 
public health and border management module. 
Main achievements 
• A protocol for assessing public health conditions and related health hazards. 
• Guidelines for public health aspects of border management and detention procedures. 
• Recommendations for structural changes in border management and controls 
involving the movement of persons, with a view to improving public health risk 
assessment and management in the new Schengen II covering the Eastern external 
borders of the EU. 
• Training materials on aspects of migration health in border management. 
1.3. European Network for Highly Infectious Diseases — project 
Programme Objective: Health Security. Area: Cross-Border Health Threats. 
The project was funded under the first Public Health Programme 2003-2008, under the 2006 
work plan, with total co-funding from the EU of € 361.925.20. The project started in July 
2007 and ended in December 2010. 
Background information 
The occurrence of highly infectious diseases represents a serious cross-border health threat 
with a possible high impact on health and the economy. Experience has highlighted the 
critical importance of the hospital setting: almost all the patients requiring isolation were 
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initially admitted to a general hospital without adequate isolation facilities and later 
transferred to a high-level isolation unit. The project revealed a high level of heterogeneity as 
well as weaknesses in terms of recognition, public health response and diagnostic and clinical 
management. Nevertheless, the proper application of infection-control measures greatly 
reduces the risk of transmission of contagious diseases in hospital settings. 
The objective of the European Network for Highly Infectious Diseases (EURONHID) was to 
create a network of national centres, identified within the participating EU Member States, as 
high-level isolation units or reference hospitals involved in the care of patients affected by 
highly infectious diseases12. 
Main achievements 
The project comprised partners from 16 Member States, bringing together a significant group 
of European clinicians experienced in the management of highly infectious diseases and 
high-level isolation units. It contributed to initiating and enhancing collaboration, 
communication and exchange of information among the highly specialised staff of the 
participating centres and establishing a wide reference network. 
The major outputs from this project were: 
• Assessment of hospitals’ preparedness and assessment of current capabilities, based 
on a commonly agreed checklist for data collection and data analysis. 
• A manual for the safe and appropriate management of patients suffering from highly 
infectious diseases in isolation facilities. 
• Consensus proposals for affordable and sustainable improvements to ensure bio 
safety and bio security. 
2. HEALTH PROMOTION 
2.1. EuroHeart — project 
http://www.ehnheart.org/euroheart/about.html 
Programme Objective: Health Promotion. Area: Cardiovascular disease. 
The project was funded under the 2006 work plan of the first Public Health Programme 
2003-2008, with total co-funding from the EU of € 1.023.993. The project started in April 
2007 and finished in March 2010. 
Background information 
                                                 
12 HIDs list: Viral Haemorrhagic Fever (marburgvirus, ebolavirus, Crimean-Congo haemorrhagic fever 
virus, and Lassa virus), and South American haemorrhagic fever (Junin, Machupo, Sabia, and 
Guanarito) viruses; SARS Co-V; multi-drug resistant M tuberculosis (known or suspected infection); 
emerging highly pathogenic strains of influenza virus; smallpox and other orthopox infections (eg, 
monkey pox, camel pox, but excluding vaccinia virus); other emerging, highly pathogenic, agents, 
including agents of deliberate release (e.g. pneumonic plague). 
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Cardiovascular disease (CVD) remains the leading cause of mortality in the European Union, 
accounting for over 2 million deaths every year. Building on developments in the area of 
tobacco, alcohol and nutrition/physical activity, the European Heart Network and the 
European Society of Cardiology agreed to pool their expertise in a joint project called 
EuroHeart. The objective of the project was to address the significant problem of CVD in 
Europe and to determine specific areas of intervention aimed at preventing avoidable deaths 
and disability. It involved partners in 21 EU countries as well as Iceland, Norway and Turkey. 
Main achievements 
• The European Heart Health Charter (http://www.ehnheart.org/euroheart/european-
health-charter.html) was launched in 30 countries and translated into 24 languages, 
mobilising broad support for CVD prevention and strengthening cross-sector 
cooperation. 
• The partners carried out studies to obtain comprehensive and comparable 
information on policies and measures with respect to CVD prevention through 
mapping and analysing national plans, policies and measures across Europe. 
(http://www.ehnheart.org/euroheart/publications-wp-5-wp-6/publication/119-cvd-
prevention-in-europe-the-unfinished-agenda.html) 
• Significant efforts were deployed to improve the awareness, diagnosis and treatment 
of CVD among women. A report ‘Red Alert for Women’s Hearts’ 
(http://www.ehnheart.org/euroheart/publications-wp-5-wp-6/publication/117-red-
alert-on-womens-hearts.html) shows that heart disease and stroke are the leading 
causes of female mortality worldwide. However, the risk for women is largely 
underestimated by the general population, and often by the medical profession itself, 
because women usually suffer from CVD 10 years later in their life than men do. 
• The ‘Heartscore’ was rolled out throughout Europe (www.HeartScore.org). This is a 
very simple tool which is used to define an individual’s risk of CVD. 
The results of this project were presented to Members of the European Parliament, at the 
April 2010 meeting of the MEP Heart Group in Brussels. 
2.2. Europlan — project 
http://www.europlanproject.eu/Home.aspx  
Programme Objective: Health Promotion. Area: Rare Diseases. 
The project was funded under the 2007 work plan of the first Public Health Programme 2003-
2008, with total cofunding from the EU of € 640.000. It started in April 2008 and ended in 
March 2011. 
Background information 
The main goal of the Europlan project was to provide national health authorities in the 
Member States with supporting tools for the development and implementation of National 
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Plans and Strategies for rare diseases in line with the Council Recommendation on Rare 
Diseases13. 
The main objectives of the project were: 
• to stimulate discussion and reach a consensus on the importance of national plans for 
structuring all relevant actions in the field of rare diseases; 
• to promote the development of national plans or strategies for rare diseases within 
EU Member States; 
• to provide an instrument to support countries in designing national plans or strategies 
for rare diseases in accordance with the Council Recommendation 13. 
Main achievements 
• Organisation of 15 national conferences, throughout the EU, bringing together 
national stakeholders, patient representatives, public health authorities, clinicians and 
other health professionals, as well as researchers and other experts to promote 
concerted action in the area of rare diseases. The conferences raised awareness of 
rare diseases as a public health issue with a European dimension, and contributed to 
the creation of momentum to launch new activities or consolidate existing activities, 
initiatives or policies. They also enabled stakeholders to make full use of the tools 
developed by the Europlan project: a guide with recommendations for the definition 
and implementation of national plans and strategies for rare diseases; a report on 
current practices and relevant cases in the field of rare diseases; and a recommended 
set of indicators for monitoring and evaluating the implementation of national 
initiatives. 
More information on the 15 conferences can be found at: 
http://www.europlanproject.eu/ContenutoPage/104/en-GB/project/national-conferences-to-
discuss-europlan-supporting-tool-locations.aspx. 
• A report on the state of the art of rare disease activities in the EU27 
(http://www.eucerd.eu/upload/file/Reports/2011ReportStateofArtRDActivities.pdf) 
was coproduced by the Europlan project and the Joint Action on the scientific 
secretariat of the rare disease taskforce (funded under the 2008 annual work plan 
with total EU cofinancing of € 749.162). The report lists all measures put in place by 
all EU Member States, whether through a fully-fledged national plan for rare 
diseases or through sets of coordinated activities in all areas, including basic and 
clinical research, health services development and practice, public health policy and 
patient support.  
2.3. European Organisation for Rare Diseases (EURORDIS) — operating grant 
http://www.eurordis.org/ 
Programme Objective: Health Promotion. Area: Rare Diseases. 
                                                 
13 European Council Recommendation on an action in the field of Rare Diseases (2009/C 151/02). 
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The operating grant, funded under the 2009 work plan of the second Health Programme 2008-
2013, cofinanced the operation of EURORDIS during 2010 with a total EU contribution of 
€ 733.000. Duration of the grant: January — December 2010. 
Background information 
The European Organisation for Rare Diseases (EURORDIS) is a non-governmental patient-
driven alliance of organisations representing more than 492 rare disease patient organisations 
in over 46 countries. The mission of EURORDIS is to build a strong pan-European 
community of patient organisations and people living with rare diseases, to be their voice at 
European level, and — directly or indirectly — to mitigate the impact of rare diseases on their 
lives. 
Main achievements 
The European Conference on Rare Diseases, held in Krakow in May 2010, was funded from 
the operating grant awarded to EURORDIS. It brought together more than 600 participants 
from 43 different countries, including the US, Canada, Israel, Tunisia and Argentina. The 
conference focused on four fundamental strategic issues for the European rare diseases 
community: 
• developing and implementing national plans for rare diseases; 
• establishing national centres of expertise and European reference networks; 
• supporting research and treatments; 
• disseminating information and developing specialised services. 
These areas need better policies in order to meet the objectives of the Council 
recommendation14 and build momentum for national plans and strategies to be implemented 
across Europe. 
More information can be found at http://www.eurordis.org/content/european-conference-rare-
diseases-%E2%80%93-ecrd-2010-krakow. 
2.4. Alzheimer Europe — operating grant 
http://www.alzheimer-europe.org/ 
Programme Objective: Health Promotion. Area: rare diseases. 
The operating grant, which was funded under the 2009 work plan of the second Health 
Programme 2008-2013, cofinanced the operation of Alzheimer Europe during 2010 with a 
total EU contribution of € 250.000. Duration of the grant: January — December 2010. 
Background information 
                                                 
14 European Council Recommendation on an action in the field of Rare Diseases (2009/C 151/02) . 
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As the European organisation representing the interests of people with dementia and their 
carers, the key aim of Alzheimer Europe is to make dementia a European priority. In its 
campaign, Alzheimer Europe used the results of European projects, such as the ‘European 
collaboration on dementia — EuroCoDe’ project or surveys of carers of people with dementia 
in different European countries. Alzheimer Europe currently has 35 member associations 
from 31 countries across Europe. 
Main achievements 
• The operating grant focused on the collection of national legislation and the 
exchange of good practice in the care and treatment of people with Alzheimer’s. 
Activities focused on the promotion of mental health and the fight against stigma. 
• The organisation also focused on the mental health of older people in the European 
Pact for mental health and well-being and its priorities of promoting the active 
inclusion of people with mental health problems in society and taking measures to 
support carers. 
• Alzheimer Europe established a network to help carers deal with ethical issues 
arising in the care of people with dementia, identify a way of promoting the active 
participation of people with dementia and carry out an inventory of laws on 
guardianship and proxy decision-making in the Member States of the European 
Union. 
• Alzheimer Europe also ensured that information on best practice in the care of 
Alzheimer's sufferers is available throughout Europe and beyond. 
3. HEALTH INFORMATION 
3.1. EU Network on Health Technology Assessment — Joint action 
http://www.eunethta.eu/ 
Programme Objective: Health information. Area: Health Technology Assessment. 
The Joint Action was funded under the second Health Programme 2008-2013, under the 2009 
work plan, with total cofunding from the EU of € 2.979.655. The project started in December 
2009 and is expected to end by December 2012. 
Background information 
Health technology is the application of scientific knowledge to health care and disease 
prevention. Health technology assessment (HTA) is a multidisciplinary process that 
summarises information about the medical, social, economic and ethical issues related to the 
use of health technology in a systematic, transparent, unbiased and robust manner. Its aim is 
to inform the formulation of safe, effective health policies that are patient-focused and seek to 
achieve best value. Despite its policy goals, HTA must always be firmly rooted in research 
and the scientific method. 
The Joint Action on HTA is part of the global action developed by DG SANCO to help 
support a coordinated network of most of the EU HTA agencies. This Joint Action aims to: 
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• produce clear guidelines on what can be better achieved on HTA at EU level; 
• avoid duplication of work between national agencies; 
• spread expertise for the benefit of all EU countries; 
• strengthen evaluations carried out by EU countries; 
• develop transparent governance tools, in particular vis à vis stakeholders; 
• produce a number of joint scientific assessments on interventions, medical devices 
and pharmaceuticals; 
• implement the Pharmaceutical Forum’s recommendations on the relative 
effectiveness of pharmaceuticals. 
Main achievements 
• The first project on cooperation in the area of HTA (EUnetHTA) had already 
developed a core model presenting a catalogue of standardised tools and 
methodologies used in HTA. To complement this initial effort, it was necessary to 
establish a basis for more structured and long-term collaboration in the field. Thus 
the common core model could be extended and used for commonly developed and 
delivered assessments of technologies or processes. 
• The development of a tri-annual work plan as the network's consolidated 
organisational basis for the future. 
• Establishment of a set of standard operating procedures for structuring collaboration 
between HTA agencies and development of a stakeholder involvement policy aimed 
at making the process more transparent. 
• Completion of a set of technical tools, such as a web-based toolkit and an 
information management system. 
3.2. eHealth Presidency Conference 
Programme Objective: Health Information. Area: eHealth. 
The Presidency Conference took place in Barcelona on 15-18 March 2010. It was funded 
under the 2009 work plan of the second Health Programme 2008-2013, with total co-funding 
from the EU of € 100.000. 
Background information 
The Spanish Presidency organised a high-level conference on eHealth, simultaneously 
bringing together the two most important European events in the eHealth area: 
• the High Level European Union Conference (EU) on eHealth; 
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• the World of Health IT (WoHIT), where the ICT world can meet businesses and 
health-care institutions and professionals, in parallel with eHealth Week in Barcelona 
in 2010 (www.ehealthweek2010.org). 
Main achievements 
Under the slogan ‘eHealth for sustainable healthcare: global changes through local actions’, 
this ministerial conference acknowledged the urgent challenges of a rapidly ageing European 
society, the lack of prevention and prediction of illnesses and the growing demand for quality 
of care. It also reiterated the need for rapid use of ICT as a cost-effective means of improving 
the health of European citizens while supporting the work of health care professionals. Thus, 
it helped to foster the adoption of eHealth in Europe and improve the accessibility, quality and 
efficiency of healthcare services for patients in Europe. 
A key outcome of the conference was the adoption of the European declaration ‘Cooperation 
for eHealth’ to promote eHealth and digital health. The declaration shows that the 
introduction and development of ICT in the healthcare area are not only the result of a 
political and strategic commitment to improve public health in Europe, but are also intended 
to link eHealth policies to policies of competitiveness, innovation and research. It is also 
necessary to foster the cohesion, social inclusion and sustainability of health systems in the 
EU. 
